Edi Easterndrug India Private Limited
About Edi Easterndrug India Private Limited
Data last updated:
Edi Easterndrug India Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 November 2022.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24239OR2022PTC041171. Its GSTIN is 21AAHCE3211F1ZE (Odisha).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harshvardhan Bhardwaj and Aman Bhardwaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.119/E Zone – A Sector – A Mancheswar Industrial Estate Mancheswar, Bhubaneswar, Odisha, India – 751010.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.6 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹3.77 Lakh (net margin 2.4%) and EBITDA of ₹16.7 Lakh (EBITDA margin 10.5%).
The company has about 24 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No.119/E Zone – A Sector – A Mancheswar Industrial Estate Mancheswar, Bhubaneswar, Odisha, India – 751010
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Edi Easterndrug India Private Limited
The main business activity of Edi Easterndrug India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Edi Easterndrug India Private Limited FY 2025 filings available
Edi Easterndrug India Private Limited reported revenue of ₹1.6 Cr (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Edi Easterndrug India Private Limited
Revenue fell 3% in the latest year. EBITDA rose 18% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Edi Easterndrug India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹16.7 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.77 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Edi Easterndrug India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 10.5% | •••• | •••• |
| Net Profit Margin | 2.4% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Edi Easterndrug India are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Edi Easterndrug India Private Limited
Edi Easterndrug India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harshvardhan Bhardwaj | Director | 14 Nov 2022 | 3 Years 11 Months | Current |
| Aman Bhardwaj | Additional Director | 08 Dec 2022 | 3 Years 10 Months | Current |
Peer Comparison of Edi Easterndrug India Private Limited
Edi Easterndrug India Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Powder Spray Industries Private Limited | ₹1.6 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Jodhpur, Rajasthan, India |
| Anupam Talc Private Limited | ₹1.6 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Udaipur, Rajasthan, India |
| Ce Organics India Private Limited | ₹1.6 Cr (FY 2024) | •••• | •••• | 483.0% | •••• | Bengaluru, Karnataka, India |
| Royalkaveri Gases Private Limited | ₹1.6 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Anekal, Karnataka, India |
| Innovac Bioscience Private Limited | ₹1.6 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Vadodara, Gujarat, India |
| Edi Easterndrug India Private Limited this company | ₹1.6 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Bhubaneswar, Odisha, India |
| Krew Instruments Private Limited | ₹1.6 Cr (FY 2024) | •••• | •••• | -44.0% | •••• | Kalyan, Maharashtra, India |
| Redevelop Biotech India Private Limited | ₹1.6 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Rudrapur, Uttarakhand, India |
| Weizur India Private Limited | ₹1.6 Cr (FY 2024) | •••• | •••• | 66.0% | •••• | Anand, Gujarat, India |
| SGMR Pharmaceuiticals Private Limited | ₹1.6 Cr (FY 2025) | •••• | •••• | -35.0% | •••• | Hyderabad, Telangana, India |
| Bionic Properties Private Limited | ₹1.6 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Bhubaneswar, Odisha, India |
Peers are the five companies nearest above and the five nearest below Edi Easterndrug India by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Edi Easterndrug India Private Limited
Edi Easterndrug India Private Limited is audited by P.K.NAYAK& CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P.K.NAYAK& CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Edi Easterndrug India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Edi Easterndrug India Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Dec 2025 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Edi Easterndrug India Private Limited
Employment history and EPFO contributions of people linked to Edi Easterndrug India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Edi Easterndrug India Private Limited
Edi Easterndrug India Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Prem Shankar Pathak ceased to be Director on 22 Nov 2025.
Credit Ratings, Litigation & Regulatory Alerts for Edi Easterndrug India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Edi Easterndrug India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Edi Easterndrug India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Edi Easterndrug India Private Limited
Edi Easterndrug India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAHCE3211F1ZE | Odisha | Active | 01 Apr 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Edi Easterndrug India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Edi Easterndrug India Private Limited
Edi Easterndrug India is an active private limited company based in Bhubaneswar, Odisha, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 November 2022 (4+ years old) and is registered under CIN U24239OR2022PTC041171.
Edi Easterndrug India reported revenue of ₹1.6 Cr for FY 2025 (down 3% YoY).
Edi Easterndrug India has 2 current directors:
- Harshvardhan Bhardwaj - Director
- Aman Bhardwaj - Additional Director
Edi Easterndrug India reported a net profit of ₹3.77 Lakh (net margin 2.4%) and EBITDA of ₹16.7 Lakh (EBITDA margin 10.5%) for FY 2025, as per its filed financial statements.
The GSTIN of Edi Easterndrug India is 21AAHCE3211F1ZE, registered in Odisha.
The CIN (Corporate Identification Number) of Edi Easterndrug India is U24239OR2022PTC041171. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Edi Easterndrug India was incorporated on 14 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Edi Easterndrug India by revenue are Powder Spray Industries Private Limited, Anupam Talc Private Limited, Ce Organics India Private Limited, Royalkaveri Gases Private Limited, Innovac Bioscience Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prem Shankar Pathak ceased to be Director on 22 Nov 2025. Aman Bhardwaj was appointed as Additional Director on 08 Dec 2022. Harshvardhan Bhardwaj was appointed as Director on 14 Nov 2022. Edi Easterndrug India has 4 board changes on record in total.
The registered office of Edi Easterndrug India is at Plot No.119E Zone – A Sector – A Mancheswar Industrial Estate Mancheswar, Bhubaneswar, Odisha, India – 751010.
Edi Easterndrug India has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh.